Skip to main content
  • Lisa-Carey-LCCC-ASCO-Recorded-Discussion

    Carey Discussed Studies of HR-Positive and HER2-Negative Advanced Breast Cancer: Overall Survival by Subtype Across Three MONALEESA Studies

    Lisa A. Carey, MD, FASCO, the L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Division of Oncology and Deputy Director of Clinical Sciences for the Lineberger Comprehensive Cancer Center, discusses findings from a pooled analysis of the MONALEESA-2, -3, and -7 trials. Among the findings was a consistent overall survival benefit with rib … Continued

  • emily-sickbert-bennett-daily-tarheel-article-urging-vaccination

    Newsworthy From the Department of Medicine, Week of November 29 – December 2

    UNC researchers working to learn more about omicron variant as 1st case is identified in US – Drs. Melissa Miller and David Wohl (CBS 17) Worried about omicron? COVID’s delta strain remains a bigger threat, UNC doctors say – Drs. Melissa Miller and David Wohl (Charlotte Observer) COVID-19 Mask Recommendations Open New Chapter in Cover Story – Dr. Emily Sickbert-Bennett (Noozhawk) … Continued

  • jacquelyne-gaddy-jacob-stein-new-diversity-curriculum

    Hematology/Oncology Diversity and Inclusion Initiatives

    UNC Lineberger Comprehensive Cancer Center Equity Council Four members of the Department of Medicine are working to bring diversity, equity and inclusion principles into critical areas of UNC Lineberger. “This is a group of 14 faculty, graduate students, and staff–and we’re in the process of identifying patients and community members–coming together to develop a system that mea … Continued

  • breast-cancer-awareness-yara-abdou-patient-frances-lucas

    Breast Cancer Awareness Month–Caring for Patients, Advancing Research

    Behind every photo is a story with the power to uplift and inspire. One year has made all the difference for Frances Lucas from Fayetteville, who was diagnosed with breast cancer in May 2020. And, it was something Dr. Yara Abdou said that set the tone for her journey. “She said, ‘I’m not only going to be your doctor, I want to be your friend,’ ” recalls Frances from her first app … Continued

  • Muss-Hy

    Muss Receives Three Research Grant Awards

    Hyman Muss, MD, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology in the Division of Oncology, recently received three research awards. From the Breast Cancer Research Foundation (BCRF), Muss received $190,000 in funding for “p16INK4a Expression, Chemotherapy Toxicity, and Aging in Women with Breast Cancer.” There is significant variability in chemotherapy-relat … Continued

  • Rose_LCCC_Headshot

    Chemotherapy Plus Immunotherapy Before Surgery is Beneficial For Invasive Bladder Cancer Outcomes

    A new study is the first to report the beneficial use of chemotherapy plus immunotherapy before surgical removal of the bladder in muscle-invasive bladder cancer (MIBC). Researchers at the UNC Lineberger Comprehensive Cancer Center led the study, reporting that the regimen reduced the invasiveness of the cancer in 56 percent of patients in a phase II clinical trial. The findings … Continued

  • jared-weiss-newsworthy-december-2021

    Roundtable Discussion: Weiss Discusses Treatment of RET-Fusion Mutations in NSCLC

    Jared Weiss, MD, associate professor in the division of oncology, led a recent discussion about a 59.year-old patient with RET-fusion-positive non–small cell lung cancer (NSCLC) during a Targeted Oncology Case-Based Roundtable event. Read a transcript of the discussion.

  • Jacob Stein, MD

    To Boost Covid-19 Vaccine Uptake, Stein Describes Early Strategy To Identify Those Who May Have Missed System-Wide Communication

    As public health leaders double down on efforts to get shots to the 30% of eligible people in the U.S. that remain unvaccinated, STAT News featured UNC Health’s unique strategy to reach those who might have fallen through the cracks. During the early days of vaccine rollout “we realized that the vast majority of this communication was being done either by email or by MyChart mess … Continued

  • jared-weiss-newsworthy-december-2021

    New Therapies For Elderly, Frail Patients With Head and Neck Cancer

    Jared Weiss, MD, associate professor of medicine in the division of oncology, commented on one of two treatment regimens that have shown promise for treating elderly or frail patients with head and neck squamous cell carcinoma, according to researchers. “These results are consistent with those observed in the dose-escalation part of the study and suggest durable efficacy,” said J … Continued

  • Experimental Drug That Boosts Immunotherapy, Shows Promise in Bladder Cancer Study

    A new study in mice found that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission. This approach shows such promise that it’s already being tested in an ongoing clinical trial in people with advanced bladder cancer. This finding, led by William Kim, MD, professor of medicine in the division of oncology and member of t … Continued